Physician profile

Matthew T Lenz

Dentist · Overland Park, KS

NPI 1477606762

$2,852.34

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$214.40

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Sirona Dental, INC. $1,500.00 2019
Align Technology, INC. $356.26 2019-2023 Invisalign System - Moderate, Invisalign First - Comprehensive
A-Dec, INC. $350.00 2020
Acteon INC $252.00 2022
Ultradent Products INC $168.53 2022
Henry Schein, INC. $144.42 2019-2024
Dentsply Sirona INC $34.83 2019-2022
Patterson Companies, INC. $20.42 2019
Orapharma, A Division of Bausch Health US, LLC $15.09 2022
Dentsply Sirona Orthodontics INC $10.79 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Matthew T Lenz

$2,852.34

in general payments reported 2019-2025

Years
2019-2024
Top company
Sirona Dental, INC.

https://glasscript.com/doctor/1059986/matthew-t-lenz

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.